Rod S Taylor1, Sarah Walker1, Neil A Smart2, Massimo F Piepoli3, Fiona C Warren1, Oriana Ciani1,4, Christopher O'Connor5, David Whellan6, Steven J Keteyian7, Andrew Coats8, Constantinos H Davos9, Hasnain M Dalal1, Kathleen Dracup10, Lorraine Evangelista11, Kate Jolly12, Jonathan Myers13, Robert S McKelvie14, Birgitta B Nilsson15, Claudio Passino16, Miles D Witham17, Gloria Y Yeh18, Ann-Dorthe O Zwisler19. 1. Institute of Health Research, University of Exeter Medical School, Exeter, UK. 2. University of New England, Armidale, Australia. 3. Cardiology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy. 4. Centre for Research on Health and Social Care Management, Bocconi University, Milan, Italy. 5. Duke Clinical Research Institute, North Carolina, NC, USA. 6. Department of Medicine, Sidney Kimmel Medical College, Philadelphia, PA, USA. 7. Department of Medicine, Henry Ford Hospital, Detroit, MI, USA. 8. IRCCS, San Raffaele Pisana, Rome, Italy. 9. Cardiovascular Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece. 10. School of Nursing, University of California San Francisco, CA, USA. 11. University of California, Irvine, CA, USA. 12. Institute of Applied Health Research, University of Birmingham, UK. 13. Palo Alto Health Care System/Stanford University, Palo Alto, CA, USA. 14. St. Joseph's Health Care Centre, London, Canada. 15. Division of Medicine, Oslo University Hospital and Faculty of Health Sciences, Oslo Metropolitan University, Norway. 16. Fondazione G. Monasterio and Scuola Superiore Sant'Anna, Pisa, Italy. 17. School of Medicine, University of Dundee, Dundee, UK. 18. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. 19. National Knowledge Centre for Rehabilitation and Palliative Care, University Hospital Odense and University of Southern Denmark, Nyborg, Denmark.
Abstract
AIMS: To undertake an individual patient data (IPD) meta-analysis to assess the impact of exercise-based cardiac rehabilitation (ExCR) in patients with heart failure (HF) on mortality and hospitalisation, and differential effects of ExCR according to patient characteristics: age, sex, ethnicity, New York Heart Association functional class, ischaemic aetiology, ejection fraction, and exercise capacity. METHODS AND RESULTS: Randomised trials of exercise training for at least 3 weeks compared with no exercise control with 6-month follow-up or longer, providing IPD time to event on mortality or hospitalisation (all-cause or HF-specific). IPD were combined into a single dataset. We used Cox proportional hazards models to investigate the effect of ExCR and the interactions between ExCR and participant characteristics. We used both two-stage random effects and one-stage fixed effect models. IPD were obtained from 18 trials including 3912 patients with HF with reduced ejection fraction. Compared to control, there was no statistically significant difference in pooled time to event estimates in favour of ExCR although confidence intervals (CIs) were wide [all-cause mortality: hazard ratio (HR) 0.83, 95% CI 0.67-1.04; HF-specific mortality: HR 0.84, 95% CI 0.49-1.46; all-cause hospitalisation: HR 0.90, 95% CI 0.76-1.06; and HF-specific hospitalisation: HR 0.98, 95% CI 0.72-1.35]. No strong evidence was found of differential intervention effects across patient characteristics. CONCLUSION: Exercise-based cardiac rehabilitation did not have a significant effect on the risk of mortality and hospitalisation in HF with reduced ejection fraction. However, uncertainty around effect estimates precludes drawing definitive conclusions.
AIMS: To undertake an individual patient data (IPD) meta-analysis to assess the impact of exercise-based cardiac rehabilitation (ExCR) in patients with heart failure (HF) on mortality and hospitalisation, and differential effects of ExCR according to patient characteristics: age, sex, ethnicity, New York Heart Association functional class, ischaemic aetiology, ejection fraction, and exercise capacity. METHODS AND RESULTS: Randomised trials of exercise training for at least 3 weeks compared with no exercise control with 6-month follow-up or longer, providing IPD time to event on mortality or hospitalisation (all-cause or HF-specific). IPD were combined into a single dataset. We used Cox proportional hazards models to investigate the effect of ExCR and the interactions between ExCR and participant characteristics. We used both two-stage random effects and one-stage fixed effect models. IPD were obtained from 18 trials including 3912 patients with HF with reduced ejection fraction. Compared to control, there was no statistically significant difference in pooled time to event estimates in favour of ExCR although confidence intervals (CIs) were wide [all-cause mortality: hazard ratio (HR) 0.83, 95% CI 0.67-1.04; HF-specific mortality: HR 0.84, 95% CI 0.49-1.46; all-cause hospitalisation: HR 0.90, 95% CI 0.76-1.06; and HF-specific hospitalisation: HR 0.98, 95% CI 0.72-1.35]. No strong evidence was found of differential intervention effects across patient characteristics. CONCLUSION: Exercise-based cardiac rehabilitation did not have a significant effect on the risk of mortality and hospitalisation in HF with reduced ejection fraction. However, uncertainty around effect estimates precludes drawing definitive conclusions.
Authors: Richard D Riley; Paul C Lambert; Jan A Staessen; Jiguang Wang; Francois Gueyffier; Lutgarde Thijs; Florent Boutitie Journal: Stat Med Date: 2008-05-20 Impact factor: 2.373
Authors: Neil A Smart; Mark Waldron; Hashbullah Ismail; Francesco Giallauria; Carlo Vigorito; Veronique Cornelissen; Gudrun Dieberg Journal: Int J Evid Based Healthc Date: 2015-03
Authors: Steven J Keteyian; Eric S Leifer; Nancy Houston-Miller; William E Kraus; Clinton A Brawner; Christopher M O'Connor; David J Whellan; Lawton S Cooper; Jerome L Fleg; Dalane W Kitzman; Alain Cohen-Solal; James A Blumenthal; David S Rendall; Ileana L Piña Journal: J Am Coll Cardiol Date: 2012-10-10 Impact factor: 24.094
Authors: Rod S Taylor; Massimo F Piepoli; Neil Smart; Andrew J S Coats; Stephen Ellis; Hayes Dalal; Christopher M O'Connor; Fiona C Warren; David Whellan; Oriana Ciani Journal: Int J Cardiol Date: 2014-04-26 Impact factor: 4.164
Authors: Rod S Taylor; Sarah Walker; Neil A Smart; Massimo F Piepoli; Fiona C Warren; Oriana Ciani; David Whellan; Christopher O'Connor; Steven J Keteyian; Andrew Coats; Constantinos H Davos; Hasnain M Dalal; Kathleen Dracup; Lorraine S Evangelista; Kate Jolly; Jonathan Myers; Birgitta B Nilsson; Claudio Passino; Miles D Witham; Gloria Y Yeh Journal: J Am Coll Cardiol Date: 2019-04-02 Impact factor: 24.094
Authors: Renata Główczyńska; Ewa Piotrowicz; Dominika Szalewska; Ryszard Piotrowicz; Ilona Kowalik; Michael J Pencina; Wojciech Zaręba; Maciej Banach; Piotr Orzechowski; Sławomir Pluta; Robert Irzmański; Zbigniew Kalarus; Grzegorz Opolski Journal: Cardiovasc Diabetol Date: 2021-05-13 Impact factor: 9.951
Authors: Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2019-01-29